CVS Invests $25M in Virtual Mental Health Clinic
CVS Health invested $25 million in Array Behavioral Care, a provider of virtual mental health care. Last year, Array’s clinicians had more than 400,000 encounters with patients.
What’s on the agenda for ENGAGE at HLTH?
Hear from patients, leading provider and payer executives, investors, and healthcare startups about how to improve the patient experience at the event, which kicks off the first day of the HLTH conference. ENGAGE at HLTH is scheduled for November 13 at the Venetian Expo in Las Vegas.
Report: Whistleblower accuses CVS of “calculated and widespread” drug pricing scheme targeting elderly patients
CVS Health intentionally prevented certain Medicare beneficiaries from accessing less expensive, generic prescriptions, according to a whistleblower lawsuit from a former senior CVS executive. Documents from the lawsuit were recently unsealed,. “In doing so, CVS Health has ensured astonishing profits for itself while passing the increased costs onto taxpayers and Part D beneficiaries,” the whistleblower […]
Who made the finals for the diagnostics 2.0 pitch track at MedCity INVEST?
The companies in the track span therapeutic drug monitoring to enhance efficacy, personal nutrition, assessing traumatic brain injury and more.
Network with healthcare executives at MedCity INVEST
In our first in-person event in two years, the MedCity INVEST conference March 28-30 at the Ritz Carlton Hotel in Chicago, there will be many opportunities to connect with startups, investors and potential collaboration partners.
CVS launches $100M venture fund
The company launched CVS Health Ventures, a corporate venture fund that will make early investments in healthcare startups. It will start with a $100 million fund.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.